{"product_id":"fortive-pestle-analysis","title":"Fortive PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Competitive Advantage Starts with This Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how political shifts, economic cycles, and tech disruption are shaping Fortive's strategic outlook in our concise PESTLE snapshot; three to five-minute read, immediate value. Ready to deepen your analysis? Purchase the full PESTLE for an actionable, exportable report and make smarter strategic or investment decisions today.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare regulation and reimbursement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFortive’s Advanced Healthcare Solutions faces FDA, EU MDR (effective May 26, 2021) and other global approvals that drive launch timing and costs, with roughly 3,000 FDA 510(k) clearances annually shaping pathways. Reimbursement shifts by CMS and private payers constrain hospital capex and adoption of diagnostics and monitoring tools amid a global medical device market near 600 billion USD in 2024. Strong post-market surveillance and quality systems reduce recall and compliance exposure. Active engagement with clinical and standards bodies can speed guideline inclusion and market uptake.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment infrastructure and industrial policy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePublic investment in transport, energy and manufacturing modernization is expanding demand for instrumentation and workflow solutions; the U.S. CHIPS Act provides about 52 billion USD for semiconductors and the IRA allocates roughly 369 billion USD in clean energy incentives, both driving factory automation spend. EU and Asian industrial policies and localization\/procurement rules reshape bidding and supply chains. Fortive can align products with funded multi‑year programs to capture project pipelines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTrade policy, tariffs, and geopolitical tensions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTariffs on electronics and components, including US Section 301 levies up to 25%, raise Fortive input costs and complicate pricing across its instruments and software segments. Geopolitical risks (U.S.–China, Russia, Middle East) threaten supply-chain continuity and market access, potentially affecting Fortive’s reported 2024 revenue of about $6.6 billion. Diversified sourcing, regional manufacturing footprints and strict customs\/origin compliance protect margins and delivery reliability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic-sector health and safety priorities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRegulatory emphasis on patient, workplace and transportation safety sustains recurring demand for Fortive’s testing, calibration and compliance tools; US health spending reached about 4.5 trillion in 2022 (CMS), underpinning large-scale safety programs. Government-funded safety standards and frequent code updates drive certified-solution preference and equipment refresh cycles, aligning with Fortive’s mission-critical positioning.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRegulatory-driven recurring demand\u003c\/li\u003e\n\u003cli\u003eGovernment standards favor certified solutions\u003c\/li\u003e\n\u003cli\u003eFortive aligned with mission-critical mandates\u003c\/li\u003e\n\u003cli\u003eCode updates drive refresh cycles\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStandards setting and interoperability mandates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGovernment and quasi-government bodies, led by the 21st Century Cures Act and CMS\/ONC rules, make API-based interoperability and cybersecurity compliance de facto prerequisites for federal and large healthcare tenders; noncompliance risks exclusion from major contracts. Early alignment shortens integration friction and sales cycles, while participation in standards groups lets Fortive help shape requirements toward its instrument and software strengths; IDC forecasts global IoT spending to reach about 1.6 trillion USD by 2025, increasing tender volume.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRegulatory drivers: 21st Century Cures Act, CMS\/ONC rules\u003c\/li\u003e\n\u003cli\u003eProcurement impact: compliance required in federal\/large tenders\u003c\/li\u003e\n\u003cli\u003eStrategic action: early alignment reduces sales cycle\u003c\/li\u003e\n\u003cli\u003eInfluence lever: standards-group participation\u003c\/li\u003e\n\u003cli\u003eMarket scale: IDC ~1.6T USD IoT spend by 2025\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePolicy risks hit industrial devices; \u003cstrong\u003e6.6B USD\u003c\/strong\u003e 2024 revenue exposed\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical risks shape Fortive via device\/regulatory approvals (FDA\/EU MDR), procurement rules (21st Century Cures\/CMS\/ONC) and trade actions (Section 301 tariffs up to 25%); CHIPS (~52B USD) and IRA (~369B USD) drive industrial demand while geopolitical tensions threaten supply chains; 2024 revenue ~6.6B USD ties exposure to policy shifts.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003eValue\/Impact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFortive 2024 revenue\u003c\/td\u003e\n\u003ctd\u003e~6.6B USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMed device market 2024\u003c\/td\u003e\n\u003ctd\u003e~600B USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCHIPS\u003c\/td\u003e\n\u003ctd\u003e~52B USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIRA\u003c\/td\u003e\n\u003ctd\u003e~369B USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTariffs\u003c\/td\u003e\n\u003ctd\u003eup to 25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect the Fortive across six dimensions—Political, Economic, Social, Technological, Environmental, and Legal—backed by current data and trends to identify risks and opportunities for executives, investors, and strategists. The analysis is forward-looking, region- and industry-specific, and ready for inclusion in business plans or investor materials.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, visually segmented PESTLE summary of Fortive that’s presentation-ready and editable for regional or business-line notes, streamlining risk discussions, team alignment, and client-ready reporting.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndustrial and healthcare capex cycles\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMacro slowdowns delay customer capex for instruments and automation as buyers push projects out, while healthcare is more resilient but not immune to funding cycles. Fortive’s backlog visibility and roughly 50%+ recurring service and consumables revenues help cushion volatility. Leading indicators such as PMI (50 threshold), hospital budgets and US hospital utilization (~60–65%) inform demand planning. Flexible cost structures and variable spend defend margins across cycles.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eForeign exchange and interest rates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFortive’s global operations expose revenue and costs to FX swings—US Dollar strength (DXY up about 4% in 2024) pressured reported results while local-currency demand remained steady.\u003c\/p\u003e\n\u003cp\u003eHigher interest rates (policy rates near 5.25–5.50% mid-2025) raise customer hurdle rates and equipment financing costs, slowing sales cycles for capital goods.\u003c\/p\u003e\n\u003cp\u003eFortive uses hedging and strategic pricing to mitigate FX volatility, and reported FY2024 free cash flow around $1.1 billion supports disciplined capital allocation despite rate regimes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply chain costs and component availability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSemiconductor and electronics availability continued to affect lead times for Fortive's precision instruments, with chip lead times remaining around 16–20 weeks in 2024, stretching product delivery schedules. Rising freight, labor and energy costs pressured gross margins despite normalization of ocean rates (Drewry WCI down roughly 70% from 2022 peaks by 2024). Dual-sourcing, higher safety stock and design-for-availability reduced dependency on constrained parts and improved resilience.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eService and software mix shift\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eFortive’s shift toward higher-value services and SaaS-like connected workflows strengthens recurring revenue and margin stability; the global SaaS market is projected at about $249B by 2025 (Statista), underscoring demand for opex models during uncertainty. ARR and net retention have become primary valuation KPIs—companies with net retention above 120% typically earn valuation premiums. Bundled service+software offerings raise customer lifetime value and lower churn.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eARR focus\u003c\/li\u003e\n\u003cli\u003eNet retention \u0026gt;120%\u003c\/li\u003e\n\u003cli\u003eOpex preference\u003c\/li\u003e\n\u003cli\u003eBundling lifts LTV, cuts churn\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eM\u0026amp;A and portfolio optimization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eFortive’s model relies on bolt-on acquisitions to extend platforms and capabilities, with deal flow and returns sensitive to valuation cycles and credit conditions; the US policy rate stood at 5.25–5.50% in mid-2025, tightening financing costs for acquisitions. Rigorous integration and FBS-driven productivity are primary levers to unlock synergies and protect margins. Pruning non-core assets refocuses capital toward higher-growth adjacencies.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eModel: bolt-on acquisitions\u003c\/li\u003e\n\u003cli\u003eMacro: US policy rate 5.25–5.50% (mid-2025)\u003c\/li\u003e\n\u003cli\u003eValue creation: FBS integration \u0026amp; productivity\u003c\/li\u003e\n\u003cli\u003ePortfolio: divest non-core to fund adjacencies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePolicy risks hit industrial devices; \u003cstrong\u003e6.6B USD\u003c\/strong\u003e 2024 revenue exposed\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMacro slowdowns delay capex while healthcare and 50%+ recurring revenue cushion volatility; PMI, hospital budgets and ~60–65% US hospital utilization guide demand. DXY +4% (2024) and policy rate 5.25–5.50% (mid‑2025) pressure reported results and acquisition finance. FY2024 FCF ~$1.1B; chip lead times 16–20 wks; SaaS market ~$249B (2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDXY (2024)\u003c\/td\u003e\n\u003ctd\u003e+4%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePolicy rate (mid‑2025)\u003c\/td\u003e\n\u003ctd\u003e5.25–5.50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY2024 FCF\u003c\/td\u003e\n\u003ctd\u003e$1.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eChip lead times (2024)\u003c\/td\u003e\n\u003ctd\u003e16–20 wks\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSaaS market (2025)\u003c\/td\u003e\n\u003ctd\u003e$249B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecurring rev\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS hospital util\u003c\/td\u003e\n\u003ctd\u003e60–65%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eFortive PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact document you’ll receive after purchase—fully formatted and ready to use. This Fortive PESTLE analysis outlines key political, economic, social, technological, legal, and environmental factors affecting the company. It delivers concise insights and practical implications to support strategic decisions and valuation work.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55675954135417,"sku":"fortive-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/fortive-pestle-analysis.png?v=1755811068","url":"https:\/\/portersfiveforce.com\/products\/fortive-pestle-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}